Jason E. Stout

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

48h-index9.5kcitations231works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(120), Mycobacterium research and diagnosis(74), Pneumocystis jirovecii pneumonia detection and treatment(34), Infectious Diseases and Tuberculosis(29), Infectious Diseases and Mycology(26)

Publications225 total

A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis
UNC Libraries·2025Open Access
Cathepsin Z is a conserved susceptibility factor underlying tuberculosis severity
PLoS Biology·2025· 1 citedOpen Access
Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design
Contemporary Clinical Trials·2025
Paired single-cell and spatial transcriptional profiling reveals a central osteopontin macrophage response mediating tuberculous granuloma formation
mBio·2025· 3 citedOpen Access
Cathepsin Z is a conserved susceptibility factor underlying tuberculosis severity
2025Open Access
Epidemiology of Healthcare Facility-Associated Nontuberculous Mycobacteria From 2012 Through 2020 in a 10-Hospital Network in the United States
Clinical Infectious Diseases·2025· 1 cited
Geographic information systems analysis to focus TB screening among people born in endemic countries
The International Journal of Tuberculosis and Lung Disease·2025
P-1891. What’s the Reason for the Consult? Identifying Clusters of Infectious Disease Consultations in an Academic Health System
Open Forum Infectious Diseases·2025Open Access
P-787. Potential Impact of Repeating Unexpected Positive Interferon Gamma Release Assays
Open Forum Infectious Diseases·2025Open Access
Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
Systematic Reviews·2025Open Access
Humoral correlate of vaccine-mediated protection from tuberculosis identified in humans and non-human primates
2024· 1 citedOpen Access
Interferon Gamma Release Assays for Tuberculosis Diagnosis
2024
A Balancing Act: Finding the Right Dose of Pyrazinamide to Treat Tuberculosis
American Journal of Respiratory and Critical Care Medicine·2024Open Access
Presenting Characteristics, Treatment, and Visual Outcomes in Streptococcal Compared to Non-Streptococcal Endophthalmitis
Cureus·2024· 1 citedOpen Access
Beyond Infection: Mortality and End-of-Life Care Associated With Infectious Disease Consultation in an Academic Health System
Clinical Infectious Diseases·2024· 6 citedOpen Access
Salvage treatment of Pneumocystis jirovecii pneumonia with micafungin and clindamycin: a case report
AME Medical Journal·2024· 1 citedOpen Access
<i>Mycobacterium immunogenum</i> acquisition from hospital tap water: a genomic and epidemiologic analysis
Journal of Clinical Microbiology·2024· 4 citedOpen Access
Comparison of Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting Tuberculosis Disease
JAMA Network Open·2024· 18 citedOpen Access
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Nature Communications·2024· 9 citedOpen Access
Impact of the COVID-19 pandemic on adult mental health-related admissions at a large university health system in North Carolina – one year into the pandemic
PLoS ONE·2023· 4 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Victor L. Yu(8), Richard J. Wallace(7), David E. Griffith(7), Charles L. Daley(6), Christoph Lange(6), Emmanuelle Cambau(6), Erik C. Böttger(6), Lorenzo Guglielmetti(6), Kenneth N. Olivier(6), Miguel Santín(6), Enrico Tortoli(6), Jakko van Ingen(6), Dirk Wagner(6), Kevin Winthrop(6), Carol Hamilton(6), Shandra L. Knight(5), Philip Leitman(5), Theodore K. Marras(5), C. Andréjak(4), Gwen A. Huitt(4)